Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Calypte Biomedical Corp.

www.calypte.com

Latest From Calypte Biomedical Corp.

Selected Start-Ups (4/00)

In Vivo summarizes the technologies of several recently founded companies: Ardais Corp., is creating information products from consolidating high-quality, reliable biological samples and related information for use in drug discovery and development. BeneCor Heart Systems was founded in September 1999 to develop and commercialize a totally implantable, permanent heart replacement device. Chronix Biomedical will focus on the diagnosis and management of chronic diseases by detecting what it calls "reshuffled genes," the detours the human genome map takes when confronted with viruses or other toxins. Founded in July 1999 by a group of former Columbia University physicians and scientists, MediData Solutions Inc. will offer new software and technology for managing clinical trials. Spiration is developing devices to treat pulmonary diseases, in particular chronic obstructive pulmonary disease (COPD), for which no cure exists.

Marketing Whizz

Calypte Biomedical just got approval for a urine-based HIV-1 confirmatory test, showing unbelievers that urine-based assays can be as sensitive--and even more sensitive--than traditional blood-based tests. Since the test's less dangerous for health care workers to handle, the company expects its fortunes to improve dramatically.
Medical Device

Diagnostics Do Well By Investors

The turbulence that began roiling the stock market in May and which by July had pulled down the prices of almost all technology stocks, hurt diagnostics companies as much as anyone else in the health care industry. But a look at the numbers behind these often ignored or maligned firms show they have fared better than most.
Medical Device Business Strategies
See All

Company Information

  • Industry
  • Biotechnology
  • In Vitro Diagnostics
    • Chemistry, Immunoassay
    • Urine-based Testing
  • Therapeutic Areas
  • Infectious & Viral Diseases
  • Alias(es)
  • Ownership
  • Public
  • Headquarters
  • Worldwide
    • North America
      • USA
  • Parent & Subsidiaries
  • Calypte Biomedical Corp.
  • Senior Management
  • Donald N Taylor, Pres. & CEO
    Ronald W Mink, CSO
    J. Daniel Clark, VP, Sales & Mktg.
    Jerrold D Dotson, VP, Fin. & Admin.
    Christopher P Kafka, VP, Bus. Dev.
  • Contact Info
  • Calypte Biomedical Corp.
    Phone: (971) 204-0282
    5 Centerpointe Dr.
    Ste. 400
    Lake Oswego, OR 97035
    USA
UsernamePublicRestriction

Register